Biagio Moretti

Biagio Moretti


Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2005 in Injury
Verified
Journal Article
Closed access
EME. Mouhsine
E. Mouhsine
RGR. Garofalo
R. Garofalo
OBO. Borens
O. Borens
MWM. Wettstein
M. Wettstein
CBC.-H. Blanc
C.-H. Blanc
PLP.-F. Leyvraz
P.-F. Leyvraz

27 May 2009 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
BMBiagio Moretti
Biagio Moretti
ANangela notarnicola
angela notarnicola
GMGiulio Maggio
Giulio Maggio
LMLorenzo Moretti
Lorenzo Moretti
MPMichele Pascone
Michele Pascone
VPVittorio Patella
Vittorio Patella
Background: Diabetes is becoming one of the most common chronic diseases, and ulcers are its most serious complication. Beginning with neuropathy, the subsequent foot wounds frequently lead to lower extremity amputation, even in the absence of critical limb ischemia. In recent years, some researchers have studied external shock wave therapy (ESWT) as a new approach to soft tissue wound healing. The rationale of this study was to evaluate if ESWT is effective in the management of neuropathic diabetic foot ulcers. Methods: We designed a randomized, prospective, controlled study in which we recruited 30 patients affected by neuropathic diabetic foot ulcers and then divided them into two groups based on different management strategies. One group was treated with standard care and shock wave therapy. The other group was treated with only standard care. The healing of the ulcers was evaluated over 20 weeks by the rate of re-epithelization. Results: After 20 weeks of treatment, 53.33% of the ESWT-treated patients had complete wound closure compared with 33.33% of the control patients, and the healing times were 60.8 and 82.2 days, respectively (p < 0.001). Significant differences in the index of the re-epithelization were observed between the two groups, with values of 2.97 mm2/die in the ESWT-group and 1.30 mm2/die in the control group (p < 0.001). Conclusion: Therefore, ESWT may be a useful adjunct in the management of diabetic foot ulceration. Trial registration: Current Controlled Trials ISRCTN21800909

1 April 2000 in The Journal of Bone and Joint Surgery. British volume
Verified
Journal Article
Closed access
GZGiovanni Zambonin
Giovanni Zambonin
CCClaudia Camerino
Claudia Camerino
GGGiovanni Greco
Giovanni Greco
VPVittorio Patella
Vittorio Patella
BMBiagio Moretti
Biagio Moretti
Maria GranoMaria Grano
Maria Grano
We have studied in vitro the effect of a hydroxyapatite (HA) tricalcium phosphate material coated with hepatocyte growth factor (HA-HGF) on cell growth, collagen synthesis and secretion of metalloproteinases (MMPs) by human osteoblasts. Cell proliferation was stimulated when osteoblasts were incubated with untreated HA and was further increased after exposure to HA-HGF. The uptake of [3H]-proline was increased after treatment with HA. When osteoblasts were exposed to HA-HGF, collagen synthesis was increased with respect to HA. The secretion of MMPs in control cells was undetectable, but in HA and HA-HGF cells MMP 2 and MMP 9 were clearly synthesised. Our results suggest that HA can promote osteoblast activity and that HGF can further increase its bioactivity.


5 October 2020 in Applied Psychology: Health and Well-Being
Verified
Journal Article
Closed access
PDF file
MBMaria Laura Bettinsoli
Maria Laura Bettinsoli
DRDaniela Di Riso
Daniela Di Riso
JNJaime L. Napier
Jaime L. Napier
LMLorenzo Moretti
Lorenzo Moretti
PBPierfrancesco Bettinsoli
Pierfrancesco Bettinsoli
BMBiagio Moretti
Biagio Moretti

1 December 2006 in Arthroscopy
Verified
Journal Article
Closed access
RGRaffaele Garofalo
Raffaele Garofalo
BJBrigitte M. Jolles
Brigitte M. Jolles
BMBiagio Moretti
Biagio Moretti
OSOlivier Siegrist
Olivier Siegrist